USA |NASDAQ |USD
Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
---|---|---|---|---|
May 17, 2022 (est) | Mar 31, 2022 | - | $-0.91 | $-0.30 |
Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
---|---|---|---|---|
May 17, 2022 (est) | Mar 31, 2022 | - | $-177.00K | $1.24M |
Jaguar Health's next estimated earnings date (based on same quarter last year's date) is May 17, 2022 for the fiscal quarter ending Mar 31, 2022.
Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
---|
Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
---|---|---|---|---|
Dec 2022 | 2 | $-0.60 | $-0.72 | $-0.48 |
Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
---|
Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
---|---|---|---|---|
Dec 2022 | 0 / 0 | $-0.60 | $-0.21 | $-0.18 |
Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
---|
Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
---|---|---|---|---|
Dec 2022 | 2 | $25.05M | $19.21M | $30.90M |
Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
---|---|---|---|---|
Mar 11, 2022 | Dec 2021 | $-0.09 | $-0.91 | -911.11% |
Nov 17, 2021 | Sep 2021 | $-0.18 | $-0.27 | -54.29% |
Aug 13, 2021 | Jun 2021 | $-0.12 | $-0.30 | -150.00% |
May 17, 2021 | Mar 2021 | $-0.06 | $-0.30 | -400.00% |
Mar 31, 2021 | Dec 2020 | $-0.30 | $0.09 | 130.00% |
Nov 16, 2020 | Sep 2020 | $-0.33 | $-0.63 | -90.91% |
Aug 13, 2020 | Jun 2020 | $-0.45 | $-1.32 | -193.33% |
Apr 3, 2020 | Mar 2020 | $-2.01 | $-2.04 | -1.49% |
Nov 14, 2019 | Sep 2019 | $-2.31 | $-6.00 | -159.74% |
Aug 14, 2019 | Jun 2019 | $-15.87 | $-45.33 | -185.63% |
May 21, 2019 | Mar 2019 | $-39.90 | $-50.40 | -26.32% |
Mar 13, 2019 | Dec 2018 | - | $-40.94 | - |
Nov 19, 2018 | Sep 2018 | $-136.50 | $-35.62 | 73.90% |
Aug 13, 2018 | Jun 2018 | - | $-53.24 | - |
Apr 9, 2018 | Mar 2018 | $-136.50 | $-54.27 | 60.24% |
Mar 14, 2018 | Dec 2017 | - | $-604.35 | - |
Nov 20, 2017 | Sep 2017 | $-136.50 | $220.50 | 261.54% |
Aug 9, 2017 | Jun 2017 | $-231.00 | $-126.00 | 45.45% |
May 15, 2017 | Mar 2017 | - | $-349.72 | - |
Feb 15, 2017 | Dec 2016 | $-0.24 | $-4.20 | -1650.00% |
Nov 14, 2016 | Sep 2016 | $-0.40 | $-4.50 | -1025.00% |
Aug 15, 2016 | Jun 2016 | $-0.38 | $-0.35 | 7.89% |
May 10, 2016 | Mar 2016 | $-0.49 | $-0.43 | 12.24% |
Mar 29, 2016 | Dec 2015 | $-0.64 | $-0.42 | 34.38% |
Nov 13, 2015 | Sep 2015 | $-0.49 | $-0.36 | 26.53% |
Aug 13, 2015 | Jun 2015 | - | $-1052.19 | - |
Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
---|---|---|---|---|
Mar 11, 2022 | Dec 2021 | $-0.75 | $-1.78 | - |
Mar 31, 2021 | Dec 2020 | $-0.85 | $-105.63 | - |
Mar 13, 2019 | Dec 2018 | $0.00 | $-184.08 | - |
Mar 14, 2018 | Dec 2017 | $0.00 | $-859.57 | - |
Feb 15, 2017 | Dec 2016 | - | $-9.48 | - |
Mar 29, 2016 | Dec 2015 | - | $-1052.97 | - |
Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
---|---|---|---|---|
Mar 11, 2022 | Dec 2021 | $8.74M | $-177.00K | - |
Nov 17, 2021 | Sep 2021 | $2.63M | $630.00K | 0.24% |
Aug 13, 2021 | Jun 2021 | $385.00K | $385.00K | 1.00% |
May 17, 2021 | Mar 2021 | $7.40M | $1.24M | 0.17% |
Mar 31, 2021 | Dec 2020 | $2.58M | $2.58M | 1.00% |
Nov 16, 2020 | Sep 2020 | $7.80M | $2.77M | 0.36% |
Aug 13, 2020 | Jun 2020 | $4.78M | $3.17M | 0.66% |
Apr 3, 2020 | Mar 2020 | $2.49M | $1.51M | 0.61% |
Nov 14, 2019 | Sep 2019 | $2.86M | $972.78K | 0.34% |
Aug 14, 2019 | Jun 2019 | $3.00M | $1.71M | 0.57% |
May 21, 2019 | Mar 2019 | - | $1.60M | - |
Mar 13, 2019 | Dec 2018 | - | $1.60M | - |
Nov 19, 2018 | Sep 2018 | - | $1.13M | - |
Aug 13, 2018 | Jun 2018 | - | $883.85K | - |
Apr 9, 2018 | Mar 2018 | $2.10M | $1.54M | 0.73% |
Mar 14, 2018 | Dec 2017 | $1.54M | $1.54M | 1.00% |
Nov 20, 2017 | Sep 2017 | - | $1.10M | - |
Aug 9, 2017 | Jun 2017 | - | $896.52K | - |
May 15, 2017 | Mar 2017 | - | $822.41K | - |
Feb 15, 2017 | Dec 2016 | - | $28.88K | - |
Nov 14, 2016 | Sep 2016 | - | $50.36K | - |
Aug 15, 2016 | Jun 2016 | - | $24.14K | - |
May 10, 2016 | Mar 2016 | - | $38.15K | - |
Mar 29, 2016 | Dec 2015 | - | $55.19K | - |
Nov 13, 2015 | Sep 2015 | - | $77.67K | - |
Aug 13, 2015 | Jun 2015 | - | $63.14K | - |
Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
---|---|---|---|---|
Mar 11, 2022 | Dec 2021 | $14.08M | $4.33M | -69.21% |
Mar 31, 2021 | Dec 2020 | $9.38M | $9.38M | 0.00% |
Mar 13, 2019 | Dec 2018 | $15.85M | $4.42M | - |
Mar 14, 2018 | Dec 2017 | $4.36M | $4.36M | 0.00% |
Feb 15, 2017 | Dec 2016 | - | $141.52K | - |
Mar 29, 2016 | Dec 2015 | - | $258.38K | - |
JAGX's next estimated earnings date (based on same quarter last year's report date) is May 17, 2022 for the fiscal quarter ending Mar 31, 2022.
Jaguar Health's previous earnings date was Mar 11, 2022 for its fiscal quarter ended Dec 31, 2021.
JAGX's earnings per share (EPS) was $-0.91, missing the consensus analysts forecast of $-0.09 by -911.11%.
The EPS was lower than the previous fiscal quarter (Sep 2021) by 237.04%, and lower than the same period a year before (Dec 2020) by -1111.11%.
Revenues were $-177.00K.
The company reported a net income of $-14.32M.JAGX ended the quarter with $4.34M in total debt, an increase of 205.85% compared to the previous quarter, and an increase of 14.62% compared to the same quarter a year before.
Jaguar Health's previous annual earnings date was Mar 11, 2022 for its fiscal year ended Dec 31, 2021.
JAGX's earnings per share (EPS) was $-1.78, missing the consensus analysts forecast of $-0.75 by 137.33% , and higher than the previous year's EPS (Dec 2020) by -98.31%.
Revenues were $4.33M, worse than the forecast of $14.08M by -69.21%, and down by -53.81% from previous year's revenue.
The company reported a net income of $-52.60M.
The company ended the fiscal year with $4.34M in total debt, an increase of 14.62% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.